Relevant to mass medication is the challenge potentially posed by an apparent trend of decreasing susceptibility of H. somni and other BRD pathogens to most of the antimicrobials used for the treatment and control of BRD ( DeDonder and Apley, 2015 ).
← all excerpts
Evolving views on bovine respiratory disease: An appraisal of selected key pathogens - Part 1.
1
—
—